Individuals Discontinuing Slimming Jabs Gain Back Weight Far More Rapidly Compared to Those on Conventional Diets

Fresh analysis reveals that individuals who discontinue blockbuster GLP-1 drugs like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who end traditional lifestyle programs.

Published data in a major medical journal demonstrates that while overweight individuals can lose about a fifth of their total mass while on the medication, the mass comes back at an estimated rate of 0.8 kg per month once they quit.

"Users purchasing such treatments need to be informed of the risk of quick weight regain when the therapy concludes," stated lead investigator Dr. Susan Jebb.

Such speed of recovery suggests a return to starting weight in about a year and a half.

Weighing Treatments

The study, which reviewed dozens of studies involving over 9,000 of patients, compared the results of GLP-1 agonists with older methods.

Scientists note that individuals who lose weight through dieting generally have a more gradual weight regain—around 0.1 kg a month—post-intervention.

Understanding the Fast Rebound

Nutrition scientists suggest the mode of action of the jabs accounts for the heightened weight return.

GLP-1 drugs mimic a body's own chemical called GLP-1, which moderates feelings of fullness.

"Artificially providing the hormone levels far above than normal might result in the body to produce less of its own natural GLP-1, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert.

"Discontinuation of this GLP-1 'fix' leads to hunger is uncontrolled, making excessive eating much more probable."

A Lifelong Issue?

Medical guidelines recommend the jabs for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes.

Professionals argue that, given the significant potential of relapse, the treatment is often life-long.

This view is echoed by drug manufacturers, who say that the findings "emphasize the chronic nature of excess weight," comparing it to managing conditions like high blood pressure.

User Experiences

Users who have come off the jabs describe a intense resurgence of cravings.

"It felt as if a trigger flipping and you become ravenous," described one woman.

This difficulty is compounded if users have not developed permanent lifestyle or habit modifications during therapy.

Widespread Interest

Figures suggest that a significant number of adults in the UK have used weight-loss jabs in the past year, with demand continuing to grow.

• Adoption is greater among females than men.
• The middle-aged age group shows the greatest level of interest.
• A large proportion obtain the medications through private prescriptions rather than the NHS.

In conclusion, clinicians stress that while these medications are potent agents for shedding pounds, they are not a permanent fix and maintained weight loss likely depends on integrated lifestyle changes.